Dr. Mitchell Sparling Davis , MD
Dermatology β’ El Paso, TX
10175 Gateway Blvd W Ste 100
El Paso, TX 799257618
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on April 1, 2021; this date does not establish years in practice.
-
Published CMS data list 42 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Ketoconazole β 15 prescription fills, including refills.
- Fluorouracil β 15 prescription fills, including refills.
- Clobetasol Propionate β 12 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See the full table Β· Guide: How to read Medicare Part D prescriber data
-
Fewer Part D prescriptions than 90% of clinicians listed under Dermatology in Texas (2024, 934 clinicians with data). Median for this group: 479. Middle half: 197 to 946.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
Practice Location & Contact Primary Location
10175 Gateway Blvd W Ste 100
El Paso, TX 799257618
NPPES lists 1 additional practice-address record in Tucson, AZ. See the list
Source: CMS NPPES NPI Registry, practice location records; release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
What Public CMS Data Show
Dermatology: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
51 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$2,003 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,835.43 across 40 records.
By nature of payment
- Food and Beverage: $1,665.45 across 38 records.
- Education: $169.98 across 2 records.
Reporting-company totals (3 largest of 13)
- Sanofi and Genzyme US Companies: $551.29 across 8 records.
- UCB, Inc.: $265.87 across 7 records.
- Regeneron Pharmaceuticals, Inc.: $221.53 across 6 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2021
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, βDoes your provider accept Medicare as full payment?β
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. Davis has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Davis as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in El Paso and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Fewer Part D prescriptions than 90% of clinicians listed under Dermatology in Texas (2024, 934 clinicians with data). Median for this group: 479. Middle half: 197 to 946.
Too few clinicians listed under Dermatology in El Paso have Medicare Part D data for 2024 to compare.
Part D drug cost
A lower Part D drug cost than 85% of clinicians listed under Dermatology in Texas (2024, 934 clinicians with data). Median for this group: $79,996. Middle half: $6,799 to $221,327.
Too few clinicians listed under Dermatology in El Paso have Medicare Part D data for 2024 to compare.
13 active clinicians are listed under Dermatology with a practice address in El Paso, TX (1,195 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in El Paso
0% of these 13 clinicians have the CMS telehealth indicator.
53.8% of these 13 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
CMS data for Part D prescriptions are available for 2024 only.
-
30-day fills
CMS data for 30-day fills are available for 2024 only.
-
Part D drug cost
CMS data for Part D drug cost are available for 2024 only.
-
Industry payments (Open Payments)
Industry payments (Open Payments) decreased 96% from $41,370.58 in 2022 to $1,835.43 in 2025.
- 2022: $41,370.58
- 2023: $38,629.42
- 2024: $572.26
- 2025: $1,835.43
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo Β· Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 β December 31, 2025): 40 records totaling $1,835.43.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $140.15 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $131.97 |
| Arcutis Biotherapeutics, Inc. |
Food and Beverage
In-kind items and services
|
Zoryve | General | $107.88 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
SKYRIZI | General | $107.86 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $99.12 |
| Janssen Pharmaceuticals, Inc |
Education
In-kind items and services
|
TREMFYA | General | $89.99 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $89.11 |
| Sanofi and Genzyme US Companies |
Education
In-kind items and services
|
DUPIXENT | General | $79.99 |
| Kerecis Limited |
Food and Beverage
Cash or cash equivalent
|
Kerecis SurgiClose | General | $51.13 |
| Kerecis Limited |
Food and Beverage
Cash or cash equivalent
|
Kerecis SurgiClose | General | $49.16 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $41.51 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $41.15 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $39.13 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
β | General | $39.08 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $38.92 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $38.65 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $37.94 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
β | General | $37.88 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
LIBTAYO | General | $37.84 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $37.25 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $36.78 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
SKYRIZI | General | $34.35 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $33.07 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
β | General | $32.98 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
β | General | $32.33 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Ketoconazole | Ketoconazole | 15 | 515 | $137.71 | β |
| Fluorouracil | Fluorouracil | 15 | 550 | $1,066.85 | 15 |
| Clobetasol Propionate | Clobetasol Propionate | 12 | 394 | $798.01 | β |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2026-10-02NUCC Taxonomy Code: 207N00000X
A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.
NUCC Taxonomy Code: 208D00000X
A physician who specializes in the general practice of diagnosing, treating, and managing patients with a variety of illnesses and conditions.
NUCC Taxonomy Code: 390200000X
An individual who is enrolled in an organized health care education/training program leading to a degree, certification, registration, and/or licensure to provide health care.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - DERMATOLOGY
I20240119001876
AZ
8527468347
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Secondary Practice Locations
6648 E Carondelet Dr
Tucson, AZ 857102119
Phone: 5208868151
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Internal Medicine
Doctor of Medicine (M.D.)
Internal Medicine
Student in an Organized Health Care Education/Training Program
Doctor of Medicine (M.D.)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Doctor of Medicine (M.D.)
Student in an Organized Health Care Education/Training Program
Doctor of Osteopathic Medicine (D.O.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 10175 GATEWAY BLVD W STE 100, EL PASO, TX 799252203 (Tel: 9152833953)
Additional practice office at 6648 E Carondelet Dr, Tucson, AZ 857102119
Recorded as MITCHELL DAVIS, MD
General Practice (license number reported to NPPES: CA 181578)
NPI status registered as active in NPPES database
Registered at 10175 GATEWAY BLVD W STE 100, EL PASO, TX 799257618 (Tel: 9152833953)
Registered at 10175 GATEWAY BLVD W STE 100, EL PASO, TX 799257618 (Tel: 9152833953)
Recorded as MITCHELL DAVIS
Student in an Organized Health Care Education/Training Program
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Dermatology Specialists in El Paso
- Dr. Michael Simpson, MD
- Dr. Jana Simpson, MD
- Dr. Adrian Guevara, MD
- Dr. Richard Vinson, MD
- Dr. Clinton King, MD
- Dr. Brett Ozanich, DO
Mailing Address
10175 Gateway Blvd W Ste 100
El Paso, TX 799252203
Phone: 9152833953